FindTrial
Sign In

Selection of chemotherapy for locally advanced rectosigmoid borderline cancer

Selection of chemotherapy for locally advanced rectosigmoid borderline cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049362
Enrollment
Unknown
Registered
2021-08-01
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectosigmoid borderline cancer

Interventions

surgery group:surgery

Sponsors

The Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Patients with pathologically confirmed rectosigmoid borderline cancer; 2.Complete follow-up records.

Exclusion criteria

Exclusion criteria: The patient died suddenly.

Design outcomes

Primary

MeasureTime frame
moderate- and high-risk groups;—

Countries

China

Contacts

Public ContactWang Xudong

The Second Hospital of Jilin University

wangxud@jlu.edu.cn+86 13514406378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026